| |
|
|
| Adoption, 43 |
| Anomalies, congenital see Congenital malformations |
| Antenatal care, standards, 15–16 |
| Apgar scores, 39 |
| Audit of standards of care, 3, 4 |
| |
Women with pre-gestational diabetes, 1, 2 |
| |
| Babies |
| |
Condition at birth, 39 |
| |
Description, 37–40 |
| |
Feeding, 44–45 |
| |
|
difficulties, 43 |
| |
|
management, 46 |
| |
|
timing, 44–45 |
| |
Gestation, 37–38 |
| |
Sex, 37 |
| |
Special care, 44 |
| |
Standards of care, 42–48 |
| |
Term, 43 |
| Birth trauma, 37, 38–39, 53 |
| Birth weight, 38, 53 |
| Blood glucose testing, 17, 23–25, 46–48 |
| |
Methods, 47 |
| Brachial plexus injury, 39 |
| Breastfeeding, 45–46, 54 |
| British Paediatric Surveillance Unit, 39 |
| Bruising, 39 |
| |
| Caesarean section, 18, 30, 39, 53 |
| |
Emergency, 30, 39 |
| |
Indications, 28–29 |
| |
Preterm, 31, 53 |
| Clinics |
| |
Multidisciplinary, 2 |
| Confidential Enquiry into Maternal and Child Health (CEMACH), 1 |
| |
Diabetes programme of care, 2, 35 |
| Congenital malformations, 1, 2, 3, 15, 32–33, 34, 50 |
| |
Groupings, 66 |
| |
Minor anomalies, 67 |
| |
Rate, 1 |
| Corticosteroids, 16–17 |
| Cyanotic episodes, 43 |
| |
| Data collection, 2 |
| |
Limitations, 4 |
| Delivery |
| |
Characteristics, 27–31 |
| |
Facilities at, 42 |
| |
Mode, 18, 28 |
| |
Preterm, 29–30 |
| |
Standards of care, 18–20 |
| |
Timing, 18 |
| Deprivation score, 11 |
| Dextrose, intravenous, 19 |
| Diabetes Education and Self-Management for Ongoing and Newly Diagnosed (DESMOND), 52 |
| Diabetes multidisciplinary resource group, 4 |
| Dose Adjustment for Normal Eating (DAFNE), 52 |
| |
| Erb's palsy, 39, 40, 53 |
| Ethnic minority groups, 1, 11, 12–13, 50 |
| European Surveillance of Congenital Anomalies (EUROCAT), 3, 33, 34 |
| |
| Fetal blood sampling, 19 |
| Fetal losses, 3 |
| Folic acid supplementation, 15, 34, 50, 51–52 |
| Fractures, 39 |
| Free-text information, 4 |
| |
| Glucagon kit, 17–18 |
| Glycosated haemoglobin (HbA1c) measurement, 17, 22, 52–53 |
| Glycaemic control, 17–18, 22–26, 50, 52–53 |
| |
Tests, 23–24 |
| |
Values, 24–25 |
| |
| Haemocue®, 47 |
| Health and Social Care Act, 3 |
| High-dependency care, 43 |
| Hyperinsulinism, 46 |
| Hypoglycaemia, 34, 37, 38, 43, 44, 45, 46, 47 |
| Hypoglycaemic episodes, 4 |
| |
| Immune system, 1 |
| Index of Multiple Deprivation (IMD) score, 11 |
| Infant feeding, 44–45 |
| |
Difficulties, 43 |
| |
Management, 46 |
| |
Timing, 44–45 |
| Infants see Babies |
| Information leaflets, 2 |
| Insulin, 1 |
| |
Intravenous, 19 |
| |
Resistance, 1 |
| Intensive care, 43 |
| International Classification of Diseases (ICD), 3, 66 |
| Intrapartum fetal heart monitoring, 19 |
| Ischaemic heart disease, 13 |
| |
| Jaundice, 44 |
| |
| Labour |
| |
Characteristics, 27–31 |
| |
Induction, 27–28, 30 |
| |
Onset, 27 |
| |
Standards of care, 18–20 |
| |
| Macrosomia, 37, 38 |
| Maternal deaths, 13 |
| Maternity services, 1 |
| Melanoma, malignant, 13 |
| Mitral valve replacement, 13 |
| |
| National Service Framework (NSF) for Diabetes, 4, 27, 54 |
| Neonatal |
| |
Care, 43, 54 |
| |
Complications, 53–54 |
| |
Death, 32, 37 |
| |
|
definition, 3 |
| Neonatal mortality rate, 1, 2 |
| Neonatal unit |
| |
Admission, 40, 42, 44 |
| |
Routine admission, 43–44, 54 |
| Neural tube defects, 15, 52 |
| |
| Pancreas, 1 |
| PBS Diabetes Population Prevalence Model, 6 |
| Perinatal death, definition, 3 |
| Perinatal mortality rate, 1, 2, 3, 32, 33–34, 35, 50 |
| Preconception care, 14–15, 20, 51–52 |
| Pre-eclampsia, 30 |
| Pre-gestational diabetes, 1 |
| Pregnancy |
| |
Care during, 20 |
| |
Diabetes in, prevalence, 6–8, 51 |
| |
Loss |
| |
Outcomes, 1, 32–35 |
| |
Terminations, 3, 51 |
| Prematurity, 37, 43 |
| Pre-pregnancy |
| |
Care, 2 |
| |
Counselling, 50 |
| Preterm delivery, 20–30, 31, 53 |
| Pulmonary embolism, 13 |
| |
| Reagent strips, 47 |
| Renal function, 4 |
| Respiratory distress, 34, 37, 43 |
| Retinal assessment, 18 |
| Rupture, uterine, 30 |
| |
| St Vincent Declaration, 1, 26, 50, 53, 54 |
| Scottish Intercollegiate Guidelines Network (SIGN), 4 |
| Separation of mother and baby, 42–43 |
| Sepsis, 13, 43 |
| Shoulder dystocia, 30, 37, 38–39, 40, 53 |
| Special care, babies, 44 |
| Standards of care |
| |
Babies, 42–48, 68–69 |
| |
Mother, 14–20, 68–69 |
| Steroid therapy, 16–17 |
| Super output area, 11 |
| Stillbirth, 53 |
| |
Definition, 3 |
| |
Rate, 2 |
| |
| Transitional care nursery, 54 |
| Trauma, birth, 37, 38–39, 53 |
| Triplets, 32 |
| Twins, 32 |
| Type 2 diabetes, 11, 50 |
| |
Prevalence in pregnancy, 51, 54 |
| |
| Ultrasound scan |
| |
First-trimester dating, 15–16 |
| Uterine rupture, 30 |
| |
| Vaginal delivery, 31 |
| |
Assisted, 39 |
| |
Spontaneous, 18 |
| |
| Women with diabetes |
| |
Characteristics, 10–11 |
|
|